122 related articles for article (PubMed ID: 34002944)
1. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma.
Fei N; Wen S; Ramanathan R; Hogg ME; Zureikat AH; Lotze MT; Bahary N; Singhi AD; Zeh HJ; Boone BA
Clin Transl Sci; 2021 Sep; 14(5):1822-1829. PubMed ID: 34002944
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer subtypes: a roadmap for precision medicine.
Torres C; Grippo PJ
Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
[TBL] [Abstract][Full Text] [Related]
3. A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.
Tang H; Ge Y; You T; Li X; Wang Y; Cheng Y; Bai C
BMC Cancer; 2023 Oct; 23(1):958. PubMed ID: 37817078
[TBL] [Abstract][Full Text] [Related]
4. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition.
Silvis MR; Silva D; Rohweder R; Schuman S; Gudipaty S; Truong A; Yap J; Affolter K; McMahon M; Kinsey C
J Exp Med; 2023 Mar; 220(3):. PubMed ID: 36719686
[TBL] [Abstract][Full Text] [Related]
5. The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy.
Ormanns S; Haas M; Remold A; Kruger S; Holdenrieder S; Kirchner T; Heinemann V; Boeck S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534865
[TBL] [Abstract][Full Text] [Related]
6. Hydroxychloroquine: Key therapeutic advances and emerging nanotechnological landscape for cancer mitigation.
Low LE; Kong CK; Yap WH; Siva SP; Gan SH; Siew WS; Ming LC; Lai-Foenander AS; Chang SK; Lee WL; Wu Y; Khaw KY; Ong YS; Tey BT; Singh SK; Dua K; Chellappan DK; Goh BH
Chem Biol Interact; 2023 Dec; 386():110750. PubMed ID: 37839513
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in targeting autophagy in cancer.
Jain V; Singh MP; Amaravadi RK
Trends Pharmacol Sci; 2023 May; 44(5):290-302. PubMed ID: 36931971
[TBL] [Abstract][Full Text] [Related]
8. Principles and current strategies for targeting autophagy for cancer treatment.
Amaravadi RK; Lippincott-Schwartz J; Yin XM; Weiss WA; Takebe N; Timmer W; DiPaola RS; Lotze MT; White E
Clin Cancer Res; 2011 Feb; 17(4):654-66. PubMed ID: 21325294
[TBL] [Abstract][Full Text] [Related]
9. Dissimilar effects of stereoisomers and racemic hydroxychloroquine on Ca
Janicki PK; Singh A; Sharma AK; Ruiz-Velasco V
Physiol Rep; 2023 Jul; 11(14):e15760. PubMed ID: 37474273
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation.
Gustafson DL; Viola LO; Towers CG; Das S; Duval DL; Van Eaton KM
Vet Comp Oncol; 2023 Dec; 21(4):726-738. PubMed ID: 37724007
[TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibition recovers deficient ICD-based cancer immunotherapy.
Li J; Cai W; Yu J; Zhou S; Li X; He Z; Ouyang D; Liu H; Wang Y
Biomaterials; 2022 Aug; 287():121651. PubMed ID: 35777331
[TBL] [Abstract][Full Text] [Related]
12. A critical role for autophagy in pancreatic cancer.
Yang S; Kimmelman AC
Autophagy; 2011 Aug; 7(8):912-3. PubMed ID: 21494085
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine and risk of development of cancers: a nationwide population-based cohort study.
Mao IC; Lin CY; Wu CL; Kor CT; Chang CC
Ther Clin Risk Manag; 2018; 14():1435-1443. PubMed ID: 30154660
[TBL] [Abstract][Full Text] [Related]
14. Targeting autophagy in cancer.
Onorati AV; Dyczynski M; Ojha R; Amaravadi RK
Cancer; 2018 Aug; 124(16):3307-3318. PubMed ID: 29671878
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production
Wabitsch S; McCallen JD; Ma C; Greten TF
STAR Protoc; 2021 Jun; 2(2):100517. PubMed ID: 34013212
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial.
Jeong IG; Lim B; Yun SC; Lim JH; Hong JH; Kim CS
Clin Cancer Res; 2021 Sep; 27(18):5004-5011. PubMed ID: 34011557
[TBL] [Abstract][Full Text] [Related]
17. Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
Rovers KP; Bakkers C; Nienhuijs SW; Burger JWA; Creemers GM; Thijs AMJ; Brandt-Kerkhof ARM; Madsen EVE; van Meerten E; Tuynman JB; Kusters M; Versteeg KS; Aalbers AGJ; Kok NFM; Buffart TE; Wiezer MJ; Boerma D; Los M; de Reuver PR; Bremers AJA; Verheul HMW; Kruijff S; de Groot DJA; Witkamp AJ; van Grevenstein WMU; Koopman M; Nederend J; Lahaye MJ; Kranenburg O; Fijneman RJA; van 't Erve I; Snaebjornsson P; Hemmer PHJ; Dijkgraaf MGW; Punt CJA; Tanis PJ; de Hingh IHJT;
JAMA Surg; 2021 Aug; 156(8):710-720. PubMed ID: 34009291
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer.
Fukahori M; Miwa K; Murotani K; Naito Y; Ushijima T; Sakaue T; Tanaka T; Nagasu S; Suga H; Kakuma T; Okabe Y; Torimura T
Medicine (Baltimore); 2021 May; 100(20):e26052. PubMed ID: 34011119
[TBL] [Abstract][Full Text] [Related]
19. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG
Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182
[TBL] [Abstract][Full Text] [Related]
20. Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial.
van der Voort A; van Ramshorst MS; van Werkhoven ED; Mandjes IA; Kemper I; Vulink AJ; Oving IM; Honkoop AH; Tick LW; van de Wouw AJ; Mandigers CM; van Warmerdam LJ; Wesseling J; Vrancken Peeters MT; Linn SC; Sonke GS
JAMA Oncol; 2021 Jul; 7(7):978-984. PubMed ID: 34014249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
